To solve the problem of cut off supply of cheap drugs, we can't rely on "fire fighting"

[China Pharmaceutical network industry trends] the news that the supply of cheap drugs is cut off is tantalizing In fact, the story of low-cost drug cut-off can be traced back to 2011: in the second half of that year, protamine was out of stock in many provinces and cities across the country, and some hospitals in Beijing were implicated and forced to "buy" hospitals with relatively small dosage Since then, all kinds of cheap drugs and commonly used drugs have almost become the norm So, who is the culprit? The answer to this question is different (to solve the problem of low-cost drug shortage, we can't rely on "fire fighting" picture source: Baidu picture) tetanus antitoxin, glucose injection The well-known drugs were labeled "emergency (rescue) drugs" in a list released by Guangdong drug trade center on May 2 However, the reason why they are listed on this list is because the enterprises "cut off the supply" The reporter contacted nearly ten enterprises on the "cut-off" list Except for two enterprises that thought that the "cut-off" was due to the distribution enterprises, the rest of the interviewees focused on the production cost (daily economic news on May 8) on this list, there are 61 drug specifications (drug specifications, such as dosage size, dosage form, etc.) for emergency (emergency) rescue drugs listed in the "cut-off" item, while the whole list shows that as many as 1004 drug specifications are cut off There's one thing in common with these drugs They don't cost too much Once the supply is cut off, the impact will be far-reaching The patients blame the hospital for being mercenary, the hospital blame the drug companies for not shipping, and the drug companies blame the upstream for taking advantage of the fire For example, in the face of the situation of supply cut-off, the statement of pharmaceutical companies is very simple: the production cost, especially the cost of raw materials, has increased too much; secondly, the monopoly of APIs is serious These two reasons, in fact, are nothing more than "exterior interior relations" There are many examples like this For example, the manufacturers of Ganmaoqing need to use morpholine guanidine as the auxiliary material But the price of this API suddenly soared from 12000 yuan per ton to about one million yuan, "which is very outrageous." The reason is very simple There are only one or two enterprises in China that can produce the API Of course, this situation is not normal In 2016, the national development and Reform Commission punished three companies, including Huazhong Pharmaceutical Co., Ltd., Shandong Xinyi Pharmaceutical Co., Ltd and Changzhou No.4 Pharmaceutical Co., Ltd., for reaching and implementing the monopoly agreement on eszolam API and tablet, with a total fine of more than 2.6 million yuan The problem is, to change this mess, a ticket is not a panacea It's normal for pharmaceutical companies to pursue profits Without a reasonable profit margin, of course, we can't expect pharmaceutical companies to open welfare homes But the current problem is that, in addition to the possibility that some pharmaceutical companies may take the opportunity to play coquetry and sell whine, more low-cost pharmaceutical companies are indeed faced with the dilemma of "double squeeze": on the one hand, the cost of APIs is squeezed, on the other hand, the low price of the bidding mechanism is forced, forcing the low-cost pharmaceutical companies to lose money and make money Drug companies said, "some places bid blindly for low prices, which also accelerates the disappearance of cheap drugs." Every time bidding, a "bloody" after the commonly used medicine has become the "cabbage price" and "floor price" But the problem is that there is always a market rule in the market Once the price is lower than the value, who can do the business at a loss for a long time? In addition to factors such as scalper selling, the shortage of cheap medicine is even more aggravating It's time to understand that there's a consensus: you can't force cheap drugs to play the game of cooking without rice To solve the problem of cut off supply of cheap drugs, we can no longer rely on the "fire fighting" method Reasonable profit and fair market are the basic premise for the survival and development of cheap drugs.